Corbenic Partners’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Corbenic Partners’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-13	Closed	-$2K	–	256
2017 Q3	$2K	Hold	13	–	–	﹤0.01%	241
2017 Q2	$2K	Hold	13	–	–	﹤0.01%	157
2017 Q1	$3K	Hold	13	–	–	﹤0.01%	171
2016 Q4	$4K	Hold	13	–	–	﹤0.01%	171
2016 Q3	$3K	Hold	13	–	–	﹤0.01%	174
2016 Q2	$5K	Hold	13	–	–	0.01%	146
2016 Q1	$9K	Hold	13	–	–	0.01%	125
2015 Q4	$14K	Hold	13	–	–	0.01%	119
2015 Q3	$12K	Hold	13	–	–	0.01%	110
2015 Q2	$9K	Hold	13	–	–	0.01%	104
2015 Q1	$30K	Hold	13	–	–	0.02%	73
2014 Q4	$14K	Hold	13	–	–	0.01%	116
2014 Q3	$14K	Buy	+13	New	+$21.9K	0.01%	72
2014 Q2	–	Sell	-3	Closed	-$6K	–	119
2014 Q1	$6K	Buy	+3	New	+$7.09K	﹤0.01%	86

Other funds holding AMPE

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

NFG

Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CCMW

Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Corbenic Partners's AMPE Position: Q4 2017 in Review

Corbenic Partners sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2017, closing a stake of 13 shares — an estimated $2K sold.

Corbenic Partners first reported a position in AMPE in Q1 2014 and held it in 14 quarters. The position peaked at $30K in Q1 2015. 55 funds tracked by Wall St. Rank hold AMPE as of Q4 2017.

Corbenic Partners reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2017 after selling out during the quarter.
Corbenic Partners sold 13 Ampio Pharmaceuticals Inc. shares in Q4 2017, an estimated $2K.
Corbenic Partners first reported a position in Ampio Pharmaceuticals Inc. in Q1 2014 and held it in 14 quarters.
Corbenic Partners's Ampio Pharmaceuticals Inc. position peaked at $30K in Q1 2015.
55 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2017.

Based on Corbenic Partners's 13F filing for Q4 2017, filed 25 Jan 2018.